KKR Makes Second Residential Investment in Stockholm with Three Asset Multifamily Development in Täby
STOCKHOLM--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the agreement with leading Swedish developer Reliwe for the forward funding of a new multifamily development in Täby, one of Stockholm's most sought-after municipalities. The transaction marks KKR's second residential investment in Sweden's capital region since the beginning of 2025.
The project in Täby comprises three residential assets with a total of 325 units and approximately 15,300 square meters of lettable area, expected to be completed in phases between 2026 and 2028. Located just 14 kilometers from Stockholm city center, the asset offers excellent public transport connectivity via a nearby train station, providing access to central Stockholm in under 20 minutes. The development is situated adjacent to Täby Centrum, one of the city's leading shopping centers, and is designed to meet high sustainability and architectural standards.
In February, KKR announced its investment in three multifamily properties in Haninge, located just south of the Stockholm city center. This second investment builds on KKR's work with local operating partner Cavendo to manage and grow its Stockholm residential strategy which now includes approximately 700 units under development.
'This transaction is another key step in our strategy to assemble a high-quality residential platform in the Stockholm region,' said Alexander Thams, Head of Nordics Real Estate at KKR. 'Täby is one of the most attractive and supply-constrained municipalities in Sweden, and this development offers modern, sustainable living in a location where rental stock is typically limited. We are pleased to continue our strategic partnership with Reliwe and further expand our footprint in a market where we are seeing strong demand and attractive opportunities.'
'We are very pleased to have concluded our second transaction with KKR, which underlines our ability to effectively source and execute attractive deals. Täby is a well-established and highly attractive residential market, and we look forward to delivering modern, high-quality, and sustainable homes,' said Gurmo Endale, Partner at Reliwe. 'We also look forward to further strengthening our strategic partnership with KKR.'
KKR has committed over SEK 6 billion to real estate investments in the Nordics, with a focus on high-quality residential and logistics assets and long-term partnerships with local developers. KKR's global real estate business invests thematically in high-quality real estate through a full range of scaled equity and debt strategies.
The new investment is being made through KKR's European Real Estate strategy.
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at www.globalatlantic.com.
About Reliwe
Reliwe is an expansive real estate development company focusing on sustainability and design to create residences to thrive in. Since its establishment, Reliwe has completed over 500 apartments and has around 2,100 apartments in production. In addition, the company has made substantial acquisitions of building rights in Sweden. Reliwe is actively expanding its presence in the Swedish real estate market and is dedicated to developing well designed residential properties. For additional information about Reliwe, please visit Reliwe's website at www.reliwe.se.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
41 minutes ago
- Business Wire
Avery Dennison to Webcast Second Quarter 2025 Earnings Conference Call
MENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Corporation (NYSE: AVY), a leading global materials science and digital identification solutions company, today announced it will host its second quarter 2025 earnings conference call at 11:00 a.m. ET on Tuesday, July 22, 2025. The company's second quarter release will be issued that morning at approximately 6:45 a.m. ET. The event will be webcast live, and the replay will be available on Avery Dennison's Investor Relations website ( About Avery Dennison Avery Dennison Corporation (NYSE: AVY) is a global materials science and digital identification solutions company. We are Making Possible™ products and solutions that help advance the industries we serve, providing branding and information solutions that optimize labor and supply chain efficiency, reduce waste, advance sustainability, circularity and transparency, and better connect brands and consumers. We design and develop labeling and functional materials, radio-frequency identification (RFID) inlays and tags, software applications that connect the physical and digital, and offerings that enhance branded packaging and carry or display information that improves the customer experience. Serving industries worldwide — including home and personal care, apparel, general retail, e-commerce, logistics, food and grocery, pharmaceuticals and automotive — we employ approximately 35,000 employees in more than 50 countries. Our reported sales in 2024 were $8.8 billion. Learn more at
Business Wire
an hour ago
- Business Wire
Zura Bio Announces Chief Financial Officer Transition
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) ('Zura Bio'), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as a non-executive employee through July 31, 2025, to support a seamless transition. "I am excited to welcome Eric to our leadership team. His broad financial expertise, combined with deep sector experience, makes him a strong strategic partner." Mr. Badial joined Zura Bio in March 2023, at the time of its business combination with JATT Acquisition Corporation. He led the development of Zura Bio's internal financial and operational systems, contributed to shaping its financial strategy, and participated in capital-raising efforts that supported the company's early growth. Mr. Hyllengren brings over 20 years of financial leadership experience in the life sciences and biotechnology sectors. He most recently served as Chief Operating Officer and Chief Financial Officer at Atara Biotherapeutics, where he led strategic finance, capital markets, operational planning, investor relations, controllership, business development, alliance management, legal, and information technology. At Atara, he played a key role in advancing capital strategy, driving cost transformation, and supporting organizational design. He previously spent 15 years at Amgen in roles spanning corporate finance, investor relations, business development, and alliance management, supporting global operations and long-range planning. His broad experience is expected to support Zura Bio's ongoing growth and operational execution. 'I am excited to welcome Eric to our leadership team,' said Robert Lisicki, Chief Executive Officer of Zura Bio. 'His broad financial expertise, combined with deep sector experience, makes him a strong strategic partner. We're confident he will elevate our leadership team and continue building the strong relationships we've established with our stakeholders as we pursue our long-term goals.' Mr. Lisicki added, 'On behalf of the Board, we thank Verender for his contributions and wish him well in his future endeavors.' Mr. Badial commented, 'Being part of Zura Bio's mission has been both rewarding and meaningful. I am proud of what we've accomplished and grateful to have worked alongside such talented and dedicated colleagues. I look forward to supporting a smooth transition.' ABOUT ZURA BIO Zura Bio is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases. The Company's pipeline includes dual-pathway product candidates designed to target key mechanisms of immune system imbalance, with the goal of improving efficacy, safety, and dosing convenience for patients. Zura Bio's lead product candidate, tibulizumab (ZB-106), is currently being evaluated in two separate Phase 2 clinical studies in adults, including TibuSURE for systemic sclerosis and TibuSHIELD for hidradenitis suppurativa. Additional product candidates, crebankitug (ZB-168) and torudokimab (ZB-880), have completed Phase 1/1b studies and are being evaluated for their potential across a range of autoimmune and inflammatory conditions. For more information, please visit FORWARD-LOOKING STATEMENTS This communication includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Words such as 'expect,' 'estimate,' 'project,' 'budget,' 'forecast,' 'anticipate,' 'intend,' 'plan,' 'may,' 'will,' 'could,' 'should,' 'believe,' 'predict,' 'potential,' 'continue,' 'strategy,' 'future,' 'opportunity,' 'would,' 'seem,' 'seek,' 'outlook,' 'goal,' 'mission,' and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These statements are based on various assumptions, whether or not identified in this communication. These forward-looking statements in this release include, but are not limited to, statements regarding: the anticipated transition of the company's Chief Financial Officer, building the company's relationships, the company's long-term goals; and expectations with respect to Zura Bio's development program. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events are difficult or impossible to predict and could differ materially from those expressed or implied in such forward-looking statements, as a result of these risks and uncertainties, which include factors set forth in documents filed, or to be filed by Zura Bio, with the Securities and Exchange Commission (SEC), including the risks and uncertainties described in the 'Risk Factors' section of Zura Bio's Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, and other filings with the SEC. Zura Bio cautions that the foregoing list of factors is not exclusive or exhaustive and not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Zura Bio gives no assurance that it will achieve its expectations. Zura Bio does not undertake or accept any obligation to update any forward-looking statements, except as required by law.
Business Wire
an hour ago
- Business Wire
Marti Announces 2025 and 2026 Investment Plan
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app Marti Technologies, Inc. ('Marti' or the 'Company') (NYSE American: MRT), and the only at scale ride-hailing operator in the country, today announced a new investment plan for 2025 and 2026. Marti's 2025 and 2026 investment plan consists of two pillars: New city launches: In light of the strong growth of its ride-hailing business in its existing cities of Istanbul, Ankara, Izmir, and Antalya, Marti is launching its business in the new cities of Bursa, Konya, Adana, Kocaeli, Mersin, and Kayseri. These new city launches expand the population living in the cities served by Marti's ride-hailing service 1.5x, from 28.8 million to 42.2 million people. In order to prioritize the growth of its service in its new cities, Marti does not foresee charging drivers in these cities a subscription fee in 2025. Ride-hailing team growth: Marti will invest in growing and increasing the capabilities of its ride-hailing team to support a full scale ride-hailing business in Türkiye. The team will grow from its current size of around 180 people to approximately 260 people, with an emphasis on hires in the technology, product, business operations, and business performance departments that are key contributors to delivering optimal rider and driver experiences. Together with these investments, Marti reiterates its 2025 revenue forecast of $34.0 million, and revises its adjusted EBITDA* forecast from $3.0M to -$17.0M. Taken together, these investments will further cement Marti's position as the leading ride-hailing operator across Türkiye. The 2025 revenue and adjusted EBITDA guidance provided herein are based on Marti's current estimates and assumptions and are not a guarantee of future performance. Such guidance is subject to significant risks and uncertainties, including the risk factors discussed in the Company's reports on file with the Securities and Exchange Commission ('SEC'), that could cause actual results to differ materially. There can be no assurance that the Company will achieve the results expressed by this guidance. * This press release does not include a reconciliation of forward-looking Adjusted EBITDA for 2025 because the Company is unable, without making unreasonable efforts, to provide a meaningful or reasonably accurate calculation or estimation of certain reconciling items which could be significant to the Company's results. Non-GAAP Financial Measures Certain financial information and data contained herein are not presented in accordance with generally accepted accounting principles of the United States ('GAAP'), including adjusted EBITDA. We define these metrics as follows: Adjusted EBITDA as depreciation, amortization, taxes, financial expenses (net of financial income) and one-time charges and non-cash adjustments, plus net income (loss). The one-time charges and non-cash adjustments are mainly comprised of customs tax provision expenses resulting from the one-time amendment of customs duties and lawsuit provision expense which the Company does not consider the provision to be reflective of its normal cash operations. About Marti: Founded in 2018, Marti is Türkiye's leading mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure. For more information, visit Cautionary Note Regarding Forward-Looking Statements Certain statements made in this press release constitute forward-looking statements within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements related to the ride-hailing business and its anticipated growth and impact on the Company's cash flow, the Company's expected revenue and adjusted EBITDA for 2025. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including the risks discussed in the Company's filings with the SEC, including the Company's Annual Report on Form 20-F. Marti undertakes no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise, except as required by law.
